Gaucher disease and SARS-CoV-2 infection: Experience from 181 patients in New York

Mostrar otras versiones (1)

SARS-CoV-2 infection carries high morbidity and mortality in individuals with chronic disorders. Its impact in rare disease populations such as Gaucher disease (GD) is unknown. In GD, decreased acid β-glucosidase activity leads to the accumulation of inflammatory glycosphingolipids and chronic myelo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fierro, Luca, Nesheiwat, Nora, Naik, Hetanshi, Narayanan, Praveena, Mistry, Pramod K., Balwani, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834197/
https://www.ncbi.nlm.nih.gov/pubmed/33353808
http://dx.doi.org/10.1016/j.ymgme.2020.12.288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834197/
https://www.ncbi.nlm.nih.gov/pubmed/33353808
http://dx.doi.org/10.1016/j.ymgme.2020.12.288

Ejemplares similares